期刊文献+

Gallbladder carcinoma: prognostic factors and therapeutic options 被引量:47

Gallbladder carcinoma: prognostic factors and therapeutic options
下载PDF
导出
摘要 The outcome of gallbladder carcinoma is poor,and the overall 5-year survival rate is less than 5%. In early-stage disease,a 5-year survival rate up to 75% can be achieved if stage-adjusted therapy is performed. There is wide geographic variability in the frequency of gallbladder carcinoma,which can only be explained by an interaction between genetic factors and their alteration. Gallstones and chronic cholecystitis are important risk factors in the formation of gallbladder malignancies. Factors such as chronic bacterial infection,primary sclerosing cholangitis,an anomalous junction of the pancreaticobiliary duct,and several types of gallbladder polyps are associated with a higher risk of gallbladder cancer. There is also an interesting correlation between risk factors and the histological type of cancer. However,despite theoretical risk factors,only a third of gallbladder carcinomas are recognized preoperatively. In most patients,the tumor is diagnosed by the pathologist after a routine cholecystectomy for a benign disease and is termed ‘‘incidental or occult gallbladder carcinoma''(IGBC). A cholecystectomy is performed frequently due to the minimal invasiveness of the laparoscopic technique. Therefore,the postoperative diagnosis of potentially curable early-stage disease is more frequent. A second radical re-resection to complete a radical cholecystectomy is required for several IGBCs. However,the literature and guidelines used in different countries differ regarding the radicality or T-stage criteria for performing a radical cholecystectomy. The NCCN guidelines and data from the German registry(GR),which records the largest number of incidental gallbladder carcinomas in Europe,indicate that carcinomas infiltrating the muscularis propria or beyond require radical surgery. According to GR data and current literature,a wedge resection with a combined dissection of the lymph nodes of the hepatoduodenal ligament is adequate for T1 b and T2 carcinomas. The reason for a radical cholecystectomy after simple CE in a formally R0 situation is either occult invasion or hepatic spread with unknown lymphogenic dissemination. Unfortunately,there are diverse interpretations and practices regarding stageadjusted therapy for gallbladder carcinoma. The current data suggest that more radical therapy is warranted. The outcome of gallbladder carcinoma is poor,and the overall 5-year survival rate is less than 5%. In early-stage disease,a 5-year survival rate up to 75% can be achieved if stage-adjusted therapy is performed. There is wide geographic variability in the frequency of gallbladder carcinoma,which can only be explained by an interaction between genetic factors and their alteration. Gallstones and chronic cholecystitis are important risk factors in the formation of gallbladder malignancies. Factors such as chronic bacterial infection,primary sclerosing cholangitis,an anomalous junction of the pancreaticobiliary duct,and several types of gallbladder polyps are associated with a higher risk of gallbladder cancer. There is also an interesting correlation between risk factors and the histological type of cancer. However,despite theoretical risk factors,only a third of gallbladder carcinomas are recognized preoperatively. In most patients,the tumor is diagnosed by the pathologist after a routine cholecystectomy for a benign disease and is termed ‘‘incidental or occult gallbladder carcinoma’’(IGBC). A cholecystectomy is performed frequently due to the minimal invasiveness of the laparoscopic technique. Therefore,the postoperative diagnosis of potentially curable early-stage disease is more frequent. A second radical re-resection to complete a radical cholecystectomy is required for several IGBCs. However,the literature and guidelines used in different countries differ regarding the radicality or T-stage criteria for performing a radical cholecystectomy. The NCCN guidelines and data from the German registry(GR),which records the largest number of incidental gallbladder carcinomas in Europe,indicate that carcinomas infiltrating the muscularis propria or beyond require radical surgery. According to GR data and current literature,a wedge resection with a combined dissection of the lymph nodes of the hepatoduodenal ligament is adequate for T1 b and T2 carcinomas. The reason for a radical cholecystectomy after simple CE in a formally R0 situation is either occult invasion or hepatic spread with unknown lymphogenic dissemination. Unfortunately,there are diverse interpretations and practices regarding stageadjusted therapy for gallbladder carcinoma. The current data suggest that more radical therapy is warranted.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第43期12211-12217,共7页 世界胃肠病学杂志(英文版)
关键词 GALLBLADDER CARCINOMA Stage-adjusted THERAPY Radic Gallbladder carcinoma Stage-adjusted therapy Radic
  • 相关文献

参考文献20

  • 1Andrea Cariati,Elisa Piromalli,Francesco Cetta.Gallbladder cancers: associated conditions, histological types, prognosis, and prevention[J]. European Journal of Gastroenterology & Hepatology . 2014 (5)
  • 2M. D’Hondt,R. Lapointe,Z. Benamira,H. Pottel,M. Plasse,R. Letourneau,A. Roy,M. Dagenais,F. Vandenbroucke-Menu.Carcinoma of the gallbladder: Patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience[J]. European Journal of Surgical Oncology . 2013 (6)
  • 3Danielle M. Hari,J. Harrison Howard,Anna M. Leung,Connie G. Chui,Myung‐Shin Sim,Anton J. Bilchik.A 21‐year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?[J]. HPB . 2012 (1)
  • 4Thorsten Goetze,Vittorio Paolucci.The prognostic impact of positive lymph nodes in stages T1 to T3 incidental gallbladder carcinoma: results of the German Registry[J]. Surgical Endoscopy . 2012 (5)
  • 5UshaDutta.Gallbladder cancer: Can newer insights improve the outcome?[J]. Journal of Gastroenterology and Hepatology . 2012 (4)
  • 6Shiva Jayaraman,William R. Jarnagin.Management of Gallbladder Cancer[J]. Gastroenterology Clinics of North America . 2010 (2)
  • 7William C. Gallahan,Jason D. Conway.Diagnosis and Management of Gallbladder Polyps[J]. Gastroenterology Clinics of North America . 2010 (2)
  • 8Thorsten Oliver Goetze,Vittorio Paolucci.Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry[J].Surgical Endoscopy.2010(9)
  • 9Correlation between Cholelithiasis and Gallbladder Carcinoma in Surgical and Autopsy Specimens[J]. Collegium Antropologicum . 2009 (2)
  • 10European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of cholestatic liver diseases[J].Journal of Hepatology.2009(2)

共引文献17

同被引文献237

引证文献47

二级引证文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部